Bacalao Giraldo, S.L.U.

Warning LetterOpen

Mr. Roberto Urrutia Beaskoa CEO, Managing Director Bacalao Giraldo, S.L.U. Pol. Ind. Goiain San Blas No. 7 Int, Goiain 01170 Legutiano Álava Spain Roberto.Urrutia@giraldofoodgroup.comIssued Sep 30, 2024Center for Food Safety and Applied Nutrition

View Letter

Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy.

Violations3

Issue DateSep 30, 2024

Product TypeFood & Beverages

StatusOpen

Letter Details

Firm: Bacalao Giraldo, S.L.U.
Location: Mr. Roberto Urrutia Beaskoa CEO, Managing Director Bacalao Giraldo, S.L.U. Pol. Ind. Goiain San Blas No. 7 Int, Goiain 01170 Legutiano Álava Spain Roberto.Urrutia@giraldofoodgroup.com
FEI Number: N/A
Country: Spain
Issue Date: September 30, 2024
Issuing Office: Center for Food Safety and Applied Nutrition
Product Type: Food & Beverages
Status: Open

Summary

Bacalao Giraldo, S.L.U., a seafood processing facility in Spain, failed to establish and implement a compliant Hazard Analysis and Critical Control Points (HACCP) plan for its refrigerated and frozen desalted cod products in modified atmosphere packaging, rendering them adulterated under federal law. During a May 2024 inspection, the FDA identified serious violations of 21 CFR 123, including the facility's failure to establish critical limits as required by the seafood HACCP regulation. The company's subsequent responses to FDA observations in June, July, and August 2024 were deemed inadequate to address the fundamental HACCP compliance deficiencies.

Bacalao Giraldo, S.L.U. FDA Warning Letter, September 30, 2024